Atul Deshpande

Atul Deshpande

Auto-generated profile, based on publicly available information

Atul Deshpande

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SZShuming Zhang
Shuming Zhang
ADAtul Deshpande
Atul Deshpande
BVBabita K. Verma
Babita K. Verma
HWHanwen Wang
Hanwen Wang
HMHaoyang Mi
Haoyang Mi
Aleksander PopelAleksander Popel
Aleksander Popel
Due to the lack of treatment options, there remains a need to advance new therapeutics in hepatocellular carcinoma (HCC). The traditional approach moves from initial molecular discovery through animal models to human trials to advance novel systemic therapies that improve treatment outcomes for patients with cancer. Computational methods that simulate tumors mathematically to describe cellular and molecular interactions are emerging as promising tools to simulate the impact of therapy entirely in silico, potentially greatly accelerating delivery of new therapeutics to patients. To facilitate the design of dosing regimens and identification of potential biomarkers for immunotherapy, we developed a new computational model to track tumor progression at the organ scale while capturing the spatial heterogeneity of the tumor in HCC. This computational model of spatial quantitative systems pharmacology was designed to simulate the effects of combination immunotherapy. The model was initiated using literature-derived parameter values and fitted to the specifics of HCC. Model validation was done through comparison with spatial multiomics data from a neoadjuvant HCC clinical trial combining anti-PD1 immunotherapy and a multitargeted tyrosine kinase inhibitor cabozantinib. Validation using spatial proteomics data from imaging mass cytometry demonstrated that closer proximity between CD8 T cells and macrophages correlated with nonresponse. We also compared the model output with Visium spatial transcriptomics profiling of samples from posttreatment tumor resections in the clinical trial and from another independent study of anti-PD1 monotherapy. Spatial transcriptomics data confirmed simulation results, suggesting the importance of spatial patterns of tumor vasculature and TGFβ in tumor and immune cell interactions. Our findings demonstrate that incorporating mathematical modeling and computer simulations with high-throughput spatial multiomics data provides a novel approach for patient outcome prediction and biomarker discovery. Significance: Incorporating mathematical modeling and computer simulations with high-throughput spatial multiomics data provides an effective approach for patient outcome prediction and biomarker discovery.

25 July 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
HMHaoyang Mi
Haoyang Mi
SSShamilene Sivagnanam
Shamilene Sivagnanam
WHWon Jin Ho
Won Jin Ho
SZShuming Zhang
Shuming Zhang
DBDaniel Bergman
Daniel Bergman
Aleksander PopelAleksander Popel
Aleksander Popel
Advancements in imaging technologies have revolutionized our ability to deeply profile pathological tissue architectures, generating large volumes of imaging data with unparalleled spatial resolution. This type of data collection, namely, spatial proteomics, offers invaluable insights into various human diseases. Simultaneously, computational algorithms have evolved to manage the increasing dimensionality of spatial proteomics inherent in this progress. Numerous imaging-based computational frameworks, such as computational pathology, have been proposed for research and clinical applications. However, the development of these fields demands diverse domain expertise, creating barriers to their integration and further application. This review seeks to bridge this divide by presenting a comprehensive guideline. We consolidate prevailing computational methods and outline a roadmap from image processing to data-driven, statistics-informed biomarker discovery. Additionally, we explore future perspectives as the field moves toward interfacing with other quantitative domains, holding significant promise for precision care in immuno-oncology.

19 April 2023 in Cell Systems
Verified
Journal Article
Closed access
ADAtul Deshpande
Atul Deshpande
MLMelanie Loth
Melanie Loth
DSDimitrios N. Sidiropoulos
Dimitrios N. Sidiropoulos
SZShuming Zhang
Shuming Zhang
LYLong Yuan
Long Yuan
EFElana J. Fertig
Elana J. Fertig

15 August 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
DSDimitrios N. Sidiropoulos
Dimitrios N. Sidiropoulos
SSSarah M. Shin
Sarah M. Shin
MWMeredith Wetzel
Meredith Wetzel
AGAlexander A. Girgis
Alexander A. Girgis
DBDaniel Bergman
Daniel Bergman
LKLuciane Kagohara
Luciane Kagohara
Pancreatic ductal adenocarcinoma (PDAC) is a rapidly progressing cancer that responds poorly to immunotherapies. Intratumoral tertiary lymphoid structures (TLS) have been associated with rare long-term PDAC survivors, but the role of TLS in PDAC and their spatial relationships within the context of the broader tumor microenvironment remain unknown. In this study, we report the generation of a spatial multiomic atlas of PDAC tumors and tumor-adjacent lymph nodes from patients treated with combination neoadjuvant immunotherapies. Using machine learning–enabled hematoxylin and eosin image classification models, imaging mass cytometry, and unsupervised gene expression matrix factorization methods for spatial transcriptomics, we characterized cellular states within and adjacent to TLS spanning distinct spatial niches and pathologic responses. Unsupervised learning identified TLS-specific spatial gene expression signatures that are significantly associated with improved survival in patients with PDAC. We identified spatial features of pathologic immune responses, including intratumoral TLS–associated B-cell maturation colocalizing with IgG dissemination and extracellular matrix remodeling. Our findings offer insights into the cellular and molecular landscape of TLS in PDACs during immunotherapy treatment.

26 June 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
MLMelissa R. Lyman
Melissa R. Lyman
JMJacob T. Mitchell
Jacob T. Mitchell
SRSidharth Raghavan
Sidharth Raghavan
LKLuciane Kagohara
Luciane Kagohara
AHAmanda L. Huff
Amanda L. Huff
NZNeeha Zaidi
Neeha Zaidi
Pancreatic ductal adenocarcinoma (PDAC) has a poor survival rate due to late detection. PDAC arises from precursor microscopic lesions, termed pancreatic intraepithelial neoplasia (PanIN), that develop at least a decade before overt disease; this provides an opportunity to intercept PanIN-to-PDAC progression. However, immune interception strategies require full understanding of PanIN and PDAC cellular architecture. Surgical specimens containing PanIN and PDAC lesions from a unique cohort of 5 treatment-naive patients with PDAC were surveyed using spatial omics (proteomic and transcriptomic). Findings were corroborated by spatial proteomics of PanIN and PDAC from tamoxifen-inducible KPC mice. We uncovered the organization of lymphoid cells into tertiary lymphoid structures (TLSs) adjacent to PanIN lesions. These TLSs lacked CD21 + CD23 + B cells compared with more mature TLSs near the PDAC border. PanINs harbored mostly CD4 + T cells, with fewer Tregs and exhausted T cells than PDAC. Peritumoral space was enriched with naive CD4 + and central memory T cells. These observations highlight the opportunity to modulate the immune microenvironment in PanINs before immune exclusion and immunosuppression emerge during progression into PDAC.

30 January 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAtul Deshpande
Atul Deshpande
LCLi-Fang Chu
Li-Fang Chu
RSRon Stewart
Ron Stewart
AGAnthony Gitter
Anthony Gitter
Advances in single-cell transcriptomics enable measuring the gene expression of individual cells, allowing cells to be ordered by their state in a dynamic biological process. Many algorithms assign ‘pseudotimes’ to each cell, representing the progress along the biological process. Ordering the expression data according to such pseudotimes can be valuable for understanding the underlying regulator-gene interactions in a biological process, such as differentiation. However, the distribution of cells sampled along a transitional process, and hence that of the pseudotimes assigned to them, is not uniform. This prevents using many standard mathematical methods for analyzing the ordered gene expression states. We present Single-cell Inference of Networks using Granger Ensembles (SINGE), an algorithm for gene regulatory network inference from single-cell gene expression data. Given ordered single-cell data, SINGE uses kernel-based Granger Causality regression, which smooths the irregular pseudotimes and missing expression values. It then aggregates the predictions from an ensemble of regression analyses with a modified Borda count to compile a ranked list of candidate interactions between transcriptional regulators and their target genes. In two mouse embryonic stem cell differentiation case studies, SINGE outperforms other contemporary algorithms for gene network reconstruction. However, a more detailed examination reveals caveats about transcriptional network reconstruction with single-cell RNA-seq data. Network inference methods, including SINGE, may have near random performance for predicting the targets of many individual regulators even if the overall performance is good. In addition, including uninformative pseudotime values can hurt the performance of network reconstruction methods. A MATLAB implementation of SINGE is available athttps://github.com/gitter-lab/SINGE.